Media coverage
14
Media coverage
Title EpicentRx Announces Completion Of First Cohort In Phase 1 "BETA PRIME" Trial With AdAPT-001 Media name/outlet TheStreet.com Country/Territory United States Date 29/09/21 URL https://www.thestreet.com/press-releases/epicentrx-announces-completion-of-first-cohort-in-phase-1-quot-beta-prime-quot-trial-with-adapt-001-15783685 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet Morningstar.com Country/Territory United States Date 29/09/21 URL https://www.morningstar.com/news/pr-newswire/20210929ph20498/epicentrx-announces-completion-of-first-cohort-in-phase-1-beta-prime-trial-with-adapt-001 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001; Cancer-targeting adenovirus enhanced with a TGFβ Trap well tolerated in patients with advanced cancer Media name/outlet PR Newswire Country/Territory United States Date 29/09/21 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet BioSpace Country/Territory United States Date 29/09/21 URL https://www.biospace.com/article/releases/epicentrx-announces-completion-of-first-cohort-in-phase-1-and-quot-beta-prime-and-quot-trial-with-adapt-001/?s=106 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet Yahoo! Finance Country/Territory United States Date 29/09/21 URL https://finance.yahoo.com/news/epicentrx-announces-completion-first-cohort-140500147.html Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet Yahoo! Finanzas Country/Territory United States Date 29/09/21 URL https://es-us.finanzas.yahoo.com/news/epicentrx-announces-completion-first-cohort-140500147.html Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet Finanzen.net Country/Territory Germany Date 29/09/21 URL https://www.finanzen.net/nachricht/aktien/epicentrx-announces-completion-of-first-cohort-in-phase-1-beta-prime-trial-with-adapt-001-10578093 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet TickerTech.com Country/Territory United States Date 29/09/21 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=202109202109291005PR_NEWS_USPR_____PH20498 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet ProfitQuotes.com Country/Territory United States Date 29/09/21 URL www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=202109202109291005PR_NEWS_USPR_____PH20498 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet ADVFN US Country/Territory United States Date 29/09/21 URL https://www.advfn.com/p.php?pid=nmona&article=86165972 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet Canadian Insider Country/Territory Canada Date 29/09/21 URL https://www.canadianinsider.com/epicentrx-announces-completion-of-first-cohort-in-phase-1-beta-prime-trial-with-adapt-001 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet Spoke.com Country/Territory United States Date 29/09/21 URL https://www.spoke.com/press_releases/6154816f28d324cfcc005b84 Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet WFMZ-TV Online Country/Territory United States Date 29/09/21 URL https://www.wfmz.com/news/pr_newswire/pr_newswire_health/epicentrx-announces-completion-of-first-cohort-in-phase-1-beta-prime-trial-with-adapt-001/article_792fc2a3-67a8-598f-a44d-ffd35e4428c7.html Persons Christopher Larson Title EpicentRx Announces Completion of First Cohort in Phase 1 "BETA PRIME" Trial with AdAPT-001 Media name/outlet KPVI Country/Territory United States Date 29/09/21 URL https://www.kpvi.com/news/national_news/epicentrx-announces-completion-of-first-cohort-in-phase-1-beta-prime-trial-with-adapt-001/article_292c58cf-41cb-5e74-9bf3-04063d5e5227.html Persons Christopher Larson